8-K - Zymeworks Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On March 2, 2026, Zymeworks BC Inc. (“ Zymeworks BC ”), a subsidiary of Zymeworks Inc. (the “ Company ”), entered in

Material Agreement

2.03

. Item 7.01 Regulation FD Disclosure On March 2, 2026, the Company and Royalty Pharma issued a joint press release announcing the entry into the Loan Agreement

Financing

7.01

(including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, a

Regulation Fd

9.01

FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 2, 2026. 104 Cover Page Interactive Data File (embedded as

Exhibits Only

Exhibits (2)

8-K

99.1

EX-99.1